Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Chemmedchem
|
December 20, 2013
Structure-based and fragment-based GPCR drug discovery
Stephen P Andrews, Giles A Brown, John A Christopher
Expert Opinion on Drug Discovery
|
October 20, 2018
Targeting adenosine A<sub>2A</sub> receptor antagonism for treatment of cancer
Miles Congreve, Giles A Brown, Alexandra Borodovsky, et al.
The Journal of Organic Chemistry
|
May 11, 2002
Sequenced reactions with samarium(II) iodide. Sequential intramolecular Reformatsky/nucleophilic acyl substitution reactions for the synthesis of medium-sized carbocycles
Gary A Molander, Giles A Brown, Isabel Storch de Gracia
Journal of Medicinal Chemistry
|
October 3, 2019
Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 Receptors
Rie Suzuki, Giles A Brown, John A Christopher, et al.
Molecular Pharmacology
|
September 20, 2015
Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor
Tomomi Sato, Jillian Baker, Tony Warne, et al.
Nature Communications
|
September 17, 2021
Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
Jon Palacios-Filardo, Matt Udakis, Giles A Brown, et al.
Nature Communications
|
December 9, 2021
Author Correction: Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
Jon Palacios-Filardo, Matt Udakis, Giles A Brown, et al.
Scientific Reports
|
January 10, 2018
Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A<sub>2A</sub> Receptor crystals
Prakash Rucktooa, Robert K Y Cheng, Elena Segala, et al.
Alzheimer'S Research & Therapy
|
April 22, 2021
Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M<sub>1</sub> receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study
Charlotte Bakker, Tim Tasker, Jan Liptrot, et al.
British Journal of Clinical Pharmacology
|
April 23, 2021
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M<sub>1</sub> -acetylcholine receptor agonist: A randomized cross-over trial
Charlotte Bakker, Samantha Prins, Jan Liptrot, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Chemmedchem
|
December 20, 2013
Structure-based and fragment-based GPCR drug discovery
Stephen P Andrews, Giles A Brown, John A Christopher
Expert Opinion on Drug Discovery
|
October 20, 2018
Targeting adenosine A<sub>2A</sub> receptor antagonism for treatment of cancer
Miles Congreve, Giles A Brown, Alexandra Borodovsky, et al.
The Journal of Organic Chemistry
|
May 11, 2002
Sequenced reactions with samarium(II) iodide. Sequential intramolecular Reformatsky/nucleophilic acyl substitution reactions for the synthesis of medium-sized carbocycles
Gary A Molander, Giles A Brown, Isabel Storch de Gracia
Journal of Medicinal Chemistry
|
October 3, 2019
Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 Receptors
Rie Suzuki, Giles A Brown, John A Christopher, et al.
Molecular Pharmacology
|
September 20, 2015
Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor
Tomomi Sato, Jillian Baker, Tony Warne, et al.
Nature Communications
|
September 17, 2021
Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
Jon Palacios-Filardo, Matt Udakis, Giles A Brown, et al.
Nature Communications
|
December 9, 2021
Author Correction: Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
Jon Palacios-Filardo, Matt Udakis, Giles A Brown, et al.
Scientific Reports
|
January 10, 2018
Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A<sub>2A</sub> Receptor crystals
Prakash Rucktooa, Robert K Y Cheng, Elena Segala, et al.
Alzheimer'S Research & Therapy
|
April 22, 2021
Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M<sub>1</sub> receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study
Charlotte Bakker, Tim Tasker, Jan Liptrot, et al.
British Journal of Clinical Pharmacology
|
April 23, 2021
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M<sub>1</sub> -acetylcholine receptor agonist: A randomized cross-over trial
Charlotte Bakker, Samantha Prins, Jan Liptrot, et al.
Page
of 2